Roberta Libener

2.1k total citations
60 papers, 1.3k citations indexed

About

Roberta Libener is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Molecular Biology. According to data from OpenAlex, Roberta Libener has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 13 papers in Biotechnology and 12 papers in Molecular Biology. Recurrent topics in Roberta Libener's work include Occupational and environmental lung diseases (44 papers), Cancer Research and Treatments (13 papers) and Pleural and Pulmonary Diseases (11 papers). Roberta Libener is often cited by papers focused on Occupational and environmental lung diseases (44 papers), Cancer Research and Treatments (13 papers) and Pleural and Pulmonary Diseases (11 papers). Roberta Libener collaborates with scholars based in Italy, United States and Malaysia. Roberta Libener's co-authors include Sara Orecchia, Federica Grosso, Mauro Tognon, Luciano Mutti, Pier‐Giacomo Betta, Luisella Righi, Giovanni Gaudino, Pier Giacomo Betta, Fernanda Martini and Giorgio V. Scagliotti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Roberta Libener

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Libener Italy 21 687 278 259 157 149 60 1.3k
Amiq Gazdhar Switzerland 22 456 0.7× 116 0.4× 386 1.5× 226 1.4× 17 0.1× 65 1.3k
Takahiro Matsui Japan 19 177 0.3× 271 1.0× 313 1.2× 295 1.9× 117 0.8× 91 1.1k
Doru T Alexandrescu United States 25 242 0.4× 567 2.0× 390 1.5× 223 1.4× 57 0.4× 77 1.7k
Hye Lim Jung South Korea 19 184 0.3× 184 0.7× 396 1.5× 371 2.4× 41 0.3× 88 1.4k
Noriyuki Ito Japan 22 293 0.4× 281 1.0× 392 1.5× 274 1.7× 104 0.7× 95 1.1k
Chao‐Cheng Huang Taiwan 23 233 0.3× 386 1.4× 524 2.0× 337 2.1× 40 0.3× 54 1.6k
Rashaud Senior United States 7 183 0.3× 137 0.5× 211 0.8× 169 1.1× 25 0.2× 11 1.1k
Yong‐Kie Wong Taiwan 24 280 0.4× 434 1.6× 470 1.8× 440 2.8× 20 0.1× 42 1.5k
Pengfei Zhou China 23 161 0.2× 654 2.4× 489 1.9× 139 0.9× 41 0.3× 54 1.5k
Peter A. Smethurst United Kingdom 27 516 0.8× 98 0.4× 463 1.8× 235 1.5× 15 0.1× 47 2.5k

Countries citing papers authored by Roberta Libener

Since Specialization
Citations

This map shows the geographic impact of Roberta Libener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Libener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Libener more than expected).

Fields of papers citing papers by Roberta Libener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Libener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Libener. The network helps show where Roberta Libener may publish in the future.

Co-authorship network of co-authors of Roberta Libener

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Libener. A scholar is included among the top collaborators of Roberta Libener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Libener. Roberta Libener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sacconi, Andrea, Francesca Sciarra, Roberta Libener, et al.. (2024). DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigation. Biomedicine & Pharmacotherapy. 175. 116662–116662. 3 indexed citations
2.
Torreggiani, Elena, Maria Rosa Iaquinta, Chiara Mazziotta, et al.. (2023). Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos. Scientific Reports. 13(1). 6501–6501. 3 indexed citations
3.
Napoli, Francesca, Ida Rapa, Roberta Libener, et al.. (2022). Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(2). 233–244. 2 indexed citations
4.
Antoniani, Barbara, Roberta Libener, Antonio Maconi, et al.. (2021). Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities. Journal of Experimental & Clinical Cancer Research. 40(1). 257–257. 5 indexed citations
5.
Gesmundo, Iacopo, Francesca Silvagno, Valentina Monica, et al.. (2020). Calcitriol Inhibits Viability and Proliferation in Human Malignant Pleural Mesothelioma Cells. Frontiers in Endocrinology. 11. 559586–559586. 12 indexed citations
6.
Bruno, Rossella, Greta Alì, Anello Marcello Poma, et al.. (2020). Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology. Journal of Molecular Diagnostics. 22(4). 457–466. 5 indexed citations
7.
Gesmundo, Iacopo, Valentina Audrito, Nicoletta Vitale, et al.. (2019). Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Proceedings of the National Academy of Sciences. 116(6). 2226–2231. 28 indexed citations
8.
Riganti, Chiara, Iris C. Salaroglio, Chiara Falcomatà, et al.. (2017). Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. OncoImmunology. 7(3). e1398874–e1398874. 34 indexed citations
9.
Patil, Namrata S., Luisella Righi, Hartmut Koeppen, et al.. (2017). Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 13(1). 124–133. 43 indexed citations
10.
Grosso, Federica, Alessandro Croce, Dario Mirabelli, et al.. (2015). Asbestos fibers in the gallbladder of patients affected by benign biliary tract diseases. European Journal of Gastroenterology & Hepatology. 27(7). 860–864. 14 indexed citations
11.
Iacono, Marco Lo, Valentina Monica, Luisella Righi, et al.. (2014). Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study. Journal of Thoracic Oncology. 10(3). 492–499. 114 indexed citations
12.
Filiberti, Rosangela, Stefano Parodi, Roberta Libener, et al.. (2013). Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA. Medical Oncology. 30(2). 543–543. 21 indexed citations
13.
Trincheri, Nicol Francesca, et al.. (2010). Aurora B kinase and malignant mesothelioma.. Journal of Clinical Oncology. 28(15_suppl). e21021–e21021. 2 indexed citations
14.
Ceresoli, Giovanni Luca, B. Castagneto, Francesco Facciolo, et al.. (2006). Malignant pleural mesothelioma. Annals of Oncology. 17. ii13–ii16. 19 indexed citations
15.
Mazzucco, Laura, D Medici, Massimo Serra, et al.. (2004). The use of autologous platelet gel to treat difficult‐to‐heal wounds: a pilot study. Transfusion. 44(7). 1013–1018. 201 indexed citations
16.
Orecchia, Sara, et al.. (2004). Aberrant E-cadherin and γ-catenin expression in malignant mesothelioma and its diagnostic and biological relevance. Lung Cancer. 45. S37–S43. 33 indexed citations
17.
Sigalotti, Luca, Sandra Coral, Maresa Altomonte, et al.. (2002). Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. British Journal of Cancer. 86(6). 979–982. 71 indexed citations
18.
Porta, Camillo, Marco Danova, Anna Maria Orengo, et al.. (2000). Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro. Journal of Cellular Physiology. 185(1). 126–134. 14 indexed citations
19.
20.
Donna, A, et al.. (1992). Quantitative analysis of nucleoli and nucleolar organizer regions in cultured primary human normal, reactive and malignant mesothelial cells. Pathology - Research and Practice. 188(4-5). 536–540. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amiq Gazdhar Breakdown of academic impact, for papers by Takahiro Matsui Breakdown of academic impact, for papers by Doru T Alexandrescu Breakdown of academic impact, for papers by Hye Lim Jung Breakdown of academic impact, for papers by Noriyuki Ito Breakdown of academic impact, for papers by Chao‐Cheng Huang Breakdown of academic impact, for papers by Rashaud Senior Breakdown of academic impact, for papers by Yong‐Kie Wong Breakdown of academic impact, for papers by Pengfei Zhou Breakdown of academic impact, for papers by Peter A. Smethurst
Rankless by CCL
2026